C
Sanofi SNY
$47.01 -$0.63-1.32% NASDAQ
Recommendation
Prev Close
$47.64
Volume
2,619,764
Avg Vol (90D)
2,435,162
Market Cap
$114.99B
Dividend & Yield
$1.60(3.36%)
52-Week Range
$44.73 - $60.12
P/E (TTM)
11.20
EPS (TTM)
$4.25
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
Analysts Can't Get Enough of These Little-Known Biopharma Stocks
6/12/2025 - MarketBeat
Sanofi's Dupixent Advances in EU with Positive CHMP Opinion
9/22/2025 - TipRanks Financial Blog
FDA Delays Key Sanofi Multiple Sclerosis Drug Decision
9/22/2025 - Benzinga
Sanofi (SNY) Advances with Dupixent for Skin Condition in EU
9/22/2025 - GuruFocus
Regeneron, Sanofi announce CHMP opinion recommending Dupixent approval
9/22/2025 - TipRanks Financial Blog
Regeneron, Sanofi announce CHMP opinion recommending Dupixent approval
9/22/2025 - The Fly
SeaCrest Wealth Management LLC Purchases New Holdings in Sanofi $SNY
9/22/2025 - MarketBeat
Regeneron And Sanofi : CHMP Recommends EU Approval Of Dupixent For Chronic Spontaneous Urticaria
9/22/2025 - Nasdaq News: Markets
Press Release: Update on the US regulatory review of tolebrutinib in non-relapsing, secondary progressive multiple sclerosis
9/22/2025 - Globe Newswire
Press Release: Sanofi and Regeneron's Dupixent to treat chronic spontaneous urticaria advances in EU with positive CHMP opinion
9/22/2025 - Globe Newswire
Dupixent (dupilumab) to Treat Chronic Spontaneous Urticaria (CSU) Advances in EU with Positive CHMP Opinion
9/22/2025 - Globe Newswire
sanofis troubled ms hopeful tolebrutinib hit fda delay
9/22/2025 - FierceBiotech.com - Biotech
10 Best Pharma Stocks to Buy According to Billionaires
9/21/2025 - Insider Monkey
CDC Advisers Recommend Against MMRV Combo Vaccine For Young Kids, Table Vote On Hep B Shot
9/19/2025 - Zero Hedge
Contravisory Investment Management Inc. Decreases Stake in Sanofi $SNY
9/19/2025 - MarketBeat
Croda International shares jump after Standard Industries unit discloses stake
9/18/2025 - Invezz News
Innate Pharma S.A. (NASDAQ:IPHA) Q2 2025 Earnings Call Transcript
9/18/2025 - Insider Monkey
Sanofi Reports Early Brivekimig Data, Signals Strong Efficacy And Good Tolerability
9/17/2025 - Benzinga
Sanofi (SNY) Fell on Tariff Uncertainty
9/17/2025 - Yahoo! Finance: News
Sanofi (SNY) Fell on Tariff Uncertainty
9/17/2025 - Insider Monkey
Futures Flat Ahead Of Royal FOMC Rumble
9/17/2025 - Zero Hedge
J.P. Morgan Keeps Their Buy Rating on Sanofi (SNYNF)
9/17/2025 - TipRanks Financial Blog
Analysts Offer Insights on Healthcare Companies: Sanofi (OtherSNYNF), Eli Lilly & Co (LLY) and AbbVie (ABBV)
9/17/2025 - TipRanks Financial Blog
Sanofi (NASDAQ:SNY) Receives Consensus Rating of "Buy" from Brokerages
9/17/2025 - Ticker Report
Analysts Think These Stocks Could More Than Double in Value
5/23/2025 - MarketBeat
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
--
EBIT (TTM)
--
Net Income (TTM)
--
Balance Sheet
Total Assets (Q)
$146.75B
Total Debt (Q)
$26.17B
Total Liabilities (Q)
$64.22B
Book Value Per Share (Q)
$67.55
Cash Flow
Cash from Operations (TTM)
--
Cash from Investing (TTM)
--
Cash from Financing (TTM)
--
Net Change in Cash (TTM)
--
Filings
Filing Date
Thursday, July 31, 2025
Period Date
Monday, June 30, 2025
Next Filing
Week of Oct 20 and 24 (est)
Price History
Loading...
Beta
0.32
7-Day Total Return
-1.34%
30-Day Total Return
-0.25%
60-Day Total Return
-2.81%
90-Day Total Return
-5.90%
Year to Date Total Return
-2.53%
1-Year Total Return
-19.01%
2-Year Total Return
-15.77%
3-Year Total Return
19.32%
5-Year Total Return
-8.70%
52-week Low
Jul 31, 2025 - $44.73
52-week High
Mar 10, 2025 - $60.12
Valuation
Market Cap
$114.99B - Large Cap
Enterprise Value
$123.45B
Price/Sales (TTM)
2.38
Price/Book (Q)
0.71
Dividends and Shares
Shares Outstanding
1.22K
Dividend Per Share (Most Recent)
$1.60
Dividend Per Share (TTM)
$1.60
Corporate Info
Website
www.sanofi.com
Phone Number
33 1 53 77 40 00
Address
46, avenue de la Grande Armée
Paris, 75017
Country
France
Year Founded
1994
Business Description
Sector
--
Industry
--
Sanofi engages in the research, development, manufacture, and marketing of therapeutic solutions. It provides immunology and inflammation, rare diseases, neurology, oncology, and other medicines... more
NASDAQ 09/22/2025 4:00PM Eastern Quotes delayed